Mikael Sellen

Title: The Innovative Contributions of Mikael Sellen

Introduction

Mikael Sellen, an accomplished inventor located in Goteborg, Sweden, has made significant strides in the field of chemistry and pharmacology. With two notable patents to his name, Sellen’s work primarily focuses on the development of prodrugs and novel cyclic sulfonium salts.

Latest Patents

Mikael Sellen's latest patents include groundbreaking research on prodrugs of thrombin inhibitors and a detailed process for the production of cyclic sulfonium salts. The latter patent describes a method to create a 5-7 membered ring cyclic sulfonium salt compound. This process involves reacting a 1.4-, 1.5-, or 1.6-diol compound or a cyclic ether compound with a mercapto compound and a strong protonic acid. The resulting cyclic sulfonium salts are not only innovative but show potential for use as initiators in cationic polymerizations. Some of these compounds are also classified as novel in their own right.

Career Highlights

Throughout his career, Mikael has been affiliated with prominent companies such as Astra AB and Ciba-Geigy Corporation. His tenure at these firms has positioned him as a leading figure in developing innovative chemical processes and compounds that could transform certain aspects of the pharmaceutical industry.

Collaborations

Mikael Sellen has collaborated with notable colleagues in his field, including Jan-Erik Nystrom and David Gustafsson. These collaborations have further enriched his research and have played a vital role in advancing his patented innovations.

Conclusion

Mikael Sellen's contributions to the field of inventions, particularly through his recent patents, showcase his dedication to innovation and excellence in chemistry. With a solid foundation built on collaboration and significant career achievements, Sellen continues to be a prominent figure worth following in the realms of chemistry and pharmaceuticals.